Walleye Capital LLC ARRIVENT BIOPHARMA INC Transaction History
Walleye Capital LLC
- $24 Billion
- Q3 2025
Number of Shares
27,768
Previous 9,454
193.72%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%